SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-038802
Filing Date
2023-06-21
Accepted
2023-06-21 16:39:12
Documents
2
Period of Report
2023-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 17461
2 EX-24 DOCUMENT attachment1.htm EX-24 3020
  Complete submission text file 0001209191-23-038802.txt   21827
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NOVAVAX INC. 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address
Dubovsky Filip (Reporting) CIK: 0001977361 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26770 | Film No.: 231030418